Skip to main content
Log in

Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In vitro studies have demonstrated increased atherogenicity of oxidized low-density lipoprotein (ox-LDL) compared to native LDL. Oxidative modification of LDL alters its structure allowing LDL to be taken up by scavenger receptors on macrophage, endothelial, and smooth muscle cells, leading to the formation of lipid-laden foam cells, the hallmark of early atherosclerotic lesions. The susceptibility of LDL to in vitro oxidation was assessed essentially by the technique described by Esterbauer et al. LDL oxidation were monitored by change in 234-absorbance in the presence and absence of pure flavonoids. Morin, genistein, apigenin and biochanin A, naringin and quercetin were used at different concentration. These flavonoids significantly inhibit in vitro LDL oxidation, genistein, morin and naringin have stronger inhibitory activity against LDL oxidation than biochanin A or apigenin. This study show that flavonoids prevent in vitro LDL oxidation and probably would be important to prevent atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Witzum JL: The oxidation hypothesis of atherosclerosis. Lancet 344: 793-798, 1994

    Google Scholar 

  2. Witzum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogeneis. J Clin Invest 88: 1785-1792, 1991

    Google Scholar 

  3. Geg KF, Brubacher GB, Stahelin HB: Plasma levels of anti-oxidant vitamins in relation to ischemic heart disease. A J Clin Nutr 45: 1368-1377, 1987

    Google Scholar 

  4. Gaziano JM, Manson JE, Buring JE, Hennekens CH: Dietary anti-oxidants and cardiovascular disease. Ann NY Acad Sci 669: 249-259, 1992

    Google Scholar 

  5. Steinbrg D: Workshop participants. Anti-oxidants in the prevention of human atherosclerosis. Circulation 85: 2338-2344, 1992

    Google Scholar 

  6. Susukawa M, Ishikawa T, Yoshuda H, Nakamura H: Effect of in vivo supplemention with low dose vitamin E on susceptibility of low density lipoprotein and high density lipoprotein to oxidative modification. J Am Coll Nutr 14: 16-52, 1995

    Google Scholar 

  7. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Komnow D: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly study. Lancet 345: 1007-1011, 1993

    Google Scholar 

  8. Hertog MGL, Kromhout D, Aravanis C et al.: Flavonoids intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155: 381-386,1995

    Google Scholar 

  9. Renaul S, Lorgeril M: Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339: 1523-1526 1992

    Google Scholar 

  10. Wagner H: In: J.L. Beal, E. Reinhard (eds). Natural Products as Medicinal Agents. Hippokrates-Verlag, Stuttgart, 1981, p 217

    Google Scholar 

  11. Kuana MT, Sawo JO, Ho CT, Rosen CT (eds).: Food Phytochemicals for Cancer Prevention. Acs Symposium Series, vols. 546/547. Acs, Washington DC, 1994

    Google Scholar 

  12. Lindgren FT, Jensen LC, Wills RD, Freeman NK: Flotation rates, molecular weights, and hydrated densities of the low density lipoproteins. Lipids 4: 337-344, 1969

    Google Scholar 

  13. Esterbauer H, Striegl G, Puhl H, Waeg G, Striegl G: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6: 67-75, 1989

    Google Scholar 

  14. Mangiapane H, Thomson J, Salter A, Brown S, Bell GD, White DA: The inhibition of the oxidation of low-density lipoprotein by (+)catechin. A naturally occurring flavonoid. Biochem pharmacol 43: 445-450, 1992

    Google Scholar 

  15. Miura S, Watanable J, Sano M: Effects of various natural anti-oxidants on the Cu++-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 18: 1-4, 1995

    Google Scholar 

  16. De whalley CV, Rankin SM, Hovlt JRS, Jessup W: Flavonoids inhibit the oxidative modification of low-density lipoproteins by macrophages. Biochem pharmacol 39: 1743-1750, 1990

    Google Scholar 

  17. Afanasev IB, Dorozhko AL, Brodoski AV, Kostyuk VA, Potapovitch AL: Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763-1769, 1989

    Google Scholar 

  18. Husain SR, Cillard J, Cillard P: Hydroxyl radical scavenging activities of flavonoids. Phytochemistry 26: 2489-2491, 1987

    Google Scholar 

  19. Thompson M, Williams CR, Elliol CEP: Stability of flavonoid of copper (11) and flavonoid anti-oxidant activity. Anal Chim Acta 85: 375-381, 1976

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naderi, G.A., Asgary, S., Sarraf-Zadegan, N. et al. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol Cell Biochem 246, 193–196 (2003). https://doi.org/10.1023/A:1023483223842

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023483223842

Navigation